Insulin receptor (INSR) is a proliferation regulator involved in aggressive behaviors in many types of cancer34.In patients with BE, the insulin/insulin-like growth factor axis can mediate cancer progression and cause hyperinsulinemia and insulin resistance. This evidence concerns the gene INS and Barrett esophagus.